GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Organon & Co (FRA:7XP) » Definitions » Other Gross PPE

Organon (FRA:7XP) Other Gross PPE : €-0 Mil (As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Organon Other Gross PPE?

Organon's Other Gross PPE for the quarter that ended in Dec. 2024 was €-0 Mil.

Organon's quarterly Other Gross PPE increased from Jun. 2024 (€1,079 Mil) to Sep. 2024 (€1,085 Mil) but then declined from Sep. 2024 (€1,085 Mil) to Dec. 2024 (€-0 Mil).

Organon's annual Other Gross PPE increased from Dec. 2022 (€0 Mil) to Dec. 2023 (€0 Mil) but then declined from Dec. 2023 (€0 Mil) to Dec. 2024 (€-0 Mil).


Organon Other Gross PPE Historical Data

The historical data trend for Organon's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Organon Other Gross PPE Chart

Organon Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Gross PPE
Get a 7-Day Free Trial - - - - -

Organon Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Other Gross PPE Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 1,085.60 1,079.50 1,084.80 -

Organon Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.


Organon Business Description

Traded in Other Exchanges
Address
30 Hudson Street, Floor 33, Jersey City, NJ, USA, 07302
Organon & Co is a science-based pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.

Organon Headlines

No Headlines